Ahad Sedaghat
Overview
Explore the profile of Ahad Sedaghat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azimi F, Khakpour G, Sedaghat A, Mostafaiee F, Kasraei H, Naseripour M
J Curr Ophthalmol
. 2025 Feb;
36(2):205-209.
PMID: 40012800
Purpose: To identify the potential genetic factors responsible for retinal capillary hemangioblastoma (RCH) and Type II granular corneal dystrophy (GCDII), with autosomal dominant inheritance. We used whole-exome sequencing (WES) in...
2.
Azimi F, Bagherzadeh K, Khakpoor G, Talebi S, Sedaghat A, Mirshahi R, et al.
Case Rep Ophthalmol
. 2025 Feb;
16(1):74-85.
PMID: 39981538
Introduction: The aim of this study was to determine the potential genetic cause of retinal capillary hemangioblastoma (RCH) with symptoms of Von Hippel-Lindau (VHL) disease. Case Presentations: Three Iranian families...
3.
Abdi F, Zand A, Mirzakhan M, Zarehosseinabadi V, Anvari P, Mirshahi R, et al.
Eur J Ophthalmol
. 2024 Sep;
:11206721241286123.
PMID: 39295313
Purpose: To compare the occurrence and characteristics of retinal displacement following direct perfluorocarbon liquid (PFCL)-silicone oil (SO) exchange versus indirect PFCL for air and air for SO exchange methods during...
4.
Singh A, Raval V, Sedaghat A, Kaliki S
Can J Ophthalmol
. 2024 Jun;
59(5):e534-e541.
PMID: 38830602
Objective: To assess the impact of evolving criteria for group E retinoblastoma on ocular survival outcomes. Design: A retrospective observational study. Methods: Single-institution consecutive case series of patients with advanced...
5.
Yesiltas Y, Zhou M, Zabor E, Oakey Z, Singh N, Sedaghat A, et al.
Br J Ophthalmol
. 2024 May;
108(12):1749-1754.
PMID: 38802168
Purpose: To report distinctive clinical and imaging features of iris freckles to differentiate them from iris nevi. Design: Retrospective observational study. Subjects: 53 patients (277 freckles) with incidental iris freckles...
6.
Javadi S, Habibi S, Sedaghat A, Naseripour M, Yousefi M
J Kidney Cancer VHL
. 2024 May;
11(2):12-17.
PMID: 38779573
This study aimed to assess the prevalence of neurological symptoms and related imaging findings in patients with von Hippel-Lindau (VHL) at Rasool Akram Hospital from September 2018 to September 2021....
7.
Sedaghat A, Raval V, Jia R, Fan X, Singh A
Can J Ophthalmol
. 2024 Apr;
59(5):e635-e641.
PMID: 38688458
No abstract available.
8.
Naseripour M, Sedaghat A, Gordiz A, Mirshahi R
J Curr Ophthalmol
. 2023 Sep;
35(1):90-92.
PMID: 37680298
Purpose: To describe a case of combined hamartoma of the retina and retinal pigment epithelium (CHRRPE) with peculiar optical coherence tomography (OCT) findings. Methods: Case report. Results: A 7-year-old girl...
9.
Rahdar A, Ahmadi M, Naseripour M, Akhtari A, Sedaghat A, Zare Hosseinabadi V, et al.
Sci Rep
. 2023 Aug;
13(1):13010.
PMID: 37563285
Retinoblastoma is a rare form of cancer that predominantly affects young children as the primary intraocular malignancy. Studies conducted in developed and some developing countries have revealed that early detection...
10.
Naseripour M, Azimi F, Talebi S, Mirshahi R, Kiaee R, Sedaghat A, et al.
Ophthalmic Genet
. 2023 Jan;
44(3):211-217.
PMID: 36715412
Background: Retinal capillary hemangioblastoma (RCH), while sporadic in some cases, is the most common and earliest manifestation of von Hippel-Lindau disease (VHL). This is the first report on different types...